The Protective Effects of Origanum vulgare L. Extract on Genetic Damage of Cyclophosphamide in Mice Blood Lymphocytes Using Micronucleus Test

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 44

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_PBRE-6-4_007

تاریخ نمایه سازی: 10 دی 1402

چکیده مقاله:

Background: Despite its various clinical applications, cyclophosphamide (CP), an alkylating chemotherapeutic agent, has demonstrated numerous side effects, including genetic toxicity. Objectives: This study investigated the protective action of Origanum vulgare L., a powerful antioxidant plant, on the genotoxicity of CP in the mice blood lymphocytes. Methods: The mice were pre-treated orally with different doses of ۵۰, ۱۰۰, ۲۰۰, or ۴۰۰ mg/kg O. vulgare ethanolic extract once a day for ۷ consecutive days. One hour after the final dose of O. vulgare, each animal received a single intraperitoneal administration of ۲۰۰ mg/kg CP. After ۲۴ hours, the preventive effect of O. vulgare was evaluated using an in vitro micronucleus (Mn) test in cytokinesis-blocked lymphocytes, which is a reliable genotoxicity test. All doses of O. vulgare caused significant reductions in the CP-induced Mn formation, which served as an indicator of DNA damage in the peripheral blood lymphocytes. Results: The total reduction of the Mn in binucleated lymphocytes were ۶۷% and ۷۵% for doses of ۲۰۰ and ۴۰۰ mg/kg of O. vulgare, respectively (P<۰.۰۰۱). The antioxidant plant demonstrated dose-dependent protective effects against CP-induced Mn formation and genotoxicity in the blood lymphocytes of the mice. O. vulgare can reduce the damage to DNA through its potent antioxidation activity and free radical scavenging properties. Conclusion: Since it is widely used as a safe herbal medicine for many diseases, O. vulgare could be used to relieve the adverse effects of cyclophosphamide, especially against the genetic damages of normal cells in patients undergoing chemotherapy.

نویسندگان

Mohammad Shokrzadeh

Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Emran Habibi

Department of Pharmacognosy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Amir Shadboorestan

Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Aroona Chabra

Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

Amirhossein Ahmadi

Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • J. Zhang, Q. Tian and S.-F. Zhou, Current Drug Therapy, ...
  • P. Perini, M. Calabrese, L. Rinaldi and P. Gallo, ۲۰۰۷ ...
  • A. M. Mahmoud, O. E. Hussein and S. A. Ramadan, ...
  • B. F. Hales, Cancer Res, ۱۹۸۲, ۴۲, ۳۰۱۶-۳۰۲۱ ...
  • A. K. Tiwari, CURRENT SCIENCE-BANGALORE-, ۲۰۰۱, ۸۱, ۱۱۷۹-۱۱۸۷ ...
  • R. Edenharder, J. Frangart, M. Hager, P. Hofmann and R. ...
  • A. Ahmadi, S. J. Hosseinimehr, F. Naghshvar, E. Hajir and ...
  • S. J. Hosseinimehr, S. Ahmadashrafi, F. Naghshvar, A. Ahmadi, S. ...
  • S. Arami, A. Ahmadi and S. A. Haeri, Cancer Biother ...
  • A. Zargari, ed., Medicinal Plants,, Tehran University Press, Tehran ...
  • M. Pirigharnaei, S. Zare, R. Heidary, J. Khara, R. EmamaliSabzi ...
  • E. Habibi, M. Shokrzadeh, A. Chabra, F. Naghshvar, R. Keshavarz-Maleki ...
  • M. Shokrzadeh, A. Ahmadi, A. Chabra, F. Naghshvar, F. Salehi, ...
  • E. Habibi, M. Shokrzadeh, A. Ahmadi, A. Chabra, F. Naghshvar ...
  • V. Lagouri, G. Blekas, M. Tsimidou, S. Kokkini and D. ...
  • A. Roofchaee, M. Irani, M. A. Ebrahimzadeh and M. R. ...
  • Karimian A, Shokrzadeh M, Ahmadi A, Toxicology and Industrial Health, ...
  • T. S. Khan, A. Sundin, C. Juhlin, E. Wilander, K. ...
  • G. B. McDonald, J. T. Slattery, M. E. Bouvier, S. ...
  • M. Murata, T. Suzuki, K. Midorikawa, S. Oikawa and S. ...
  • A. Chabra, M. Shokrzadeh, F. Naghshvar, F. Salehi and A. ...
  • M. Shokrzadeh, A. Chabra, A. Ahmadi, F. Naghshvar, E. Habibi, ...
  • M. Shokrzadeh, A. Chabra, F. Naghshvar, A. Ahmadi, M. Jafarinejhad ...
  • F. Moore, G. Urda, G. Krishna and J. Theiss, Mutation ...
  • U. B. Das, M. Mallick, J. M. Debnath and D. ...
  • D. Ghosh, U. B. Das, S. Ghosh, M. Mallick and ...
  • K. Manda and A. L. Bhatia, Cell Biol Toxicol, ۲۰۰۳, ...
  • J. Navarova, E. Ujhazy and M. Dubovicky, Gen Physiol Biophys, ...
  • P. Pratheeshkumar and G. Kuttan, Inflammopharmacology, ۲۰۱۰, ۱۸, ۱۹۷-۲۰۷ ...
  • V. Sheibani, M. Afarinesh, Z. Hajializadeh, M. Abbasnejad, T. Haghpanah, ...
  • T. Kulisic, A. Krisko, V. Dragovic-Uzelac, M. Milos and G. ...
  • H. Matsuura, H. Chiji, C. Asakawa, M. Amano, T. Yoshihara ...
  • M. Halici, F. Odabasoglu, H. Suleyman, A. Cakir, A. Aslan ...
  • F. Odabasoglu, A. Aslan, A. Cakir, H. Suleyman, Y. Karagoz, ...
  • A. Russo, F. Bonina, R. Acquaviva, A. Campisi, F. Galvano, ...
  • A. Di Sotto, G. Mazzanti, F. Carbone, P. Hrelia and ...
  • R. J. Lambert, P. N. Skandamis, P. J. Coote and ...
  • نمایش کامل مراجع